# Nanyang Central Hospital

Organization · id `cardio:org-nanyang-central-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Nanyang+Central+Hospital>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Nanyang Central Hospital
- Sponsor class: OTHER

## Connected pages

- Sponsors: Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2) (`cardio:ct-nct04681651`)
- Sponsors: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L) (`cardio:ct-nct05965193`)
- Sponsors: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3) (`cardio:ct-nct05965687`)
- Sponsors: Tirofiban After Successful MT Recanalization in AIS (`cardio:ct-nct06265051`)
- Sponsors: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (`cardio:ct-nct06696820`)
- Sponsors: Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes (`cardio:ct-nct07674004`)

## Provenance

Content hash: 06ee7da8f10e70c8c07ec610896046e24db65d432151c1c6b19910ac67529128
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
